Initially 600 mg 3 times in a week, may be increased to 6 times in a week depending on the severity In Moderate to Severe Disease: 600 mg to 2.4 g twice daily by intramuscular or slow intravenous injection
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared 5-Amino-1MQ for therapeutic use in humans or animals
Find answers to common questions about shipping, ordering, research use, and product information
This includes transparent reporting of synthesis conditions, purification steps, surface chemistry, size and charge data, PLQY, and biological testing protocols, alongside in vitro and in vivo dosing regimens with validated positive and negative controls [174]
It's the bedrock of reliable data